相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype
Maximilian Linxweiler et al.
CLINICAL CANCER RESEARCH (2020)
Immune-resistant mechanisms in cancer immunotherapy
Yutaka Kawakami et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Resistance to Checkpoint Inhibition in Cancer Immunotherapy
Luisa Barrueto et al.
TRANSLATIONAL ONCOLOGY (2020)
Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer
Christian Sordo-Bahamonde et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Immunotherapy Is Now First-line Therapy for Some Colorectal Cancers
Rebecca Voelker
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The Inhibitor of Apoptosis Protein Livin Confers Resistance to Fas-Mediated Immune Cytotoxicity in Refractory Lymphoma
Eiji Sugihara et al.
CANCER RESEARCH (2020)
Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer
Justin T. Gibson et al.
FRONTIERS IN IMMUNOLOGY (2020)
How to make the best use of immunotherapy as first-line treatment of advanced/metastatic non-small-cell lung cancer
S. Peters et al.
ANNALS OF ONCOLOGY (2019)
Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma
Matthew K. Labriola et al.
CLINICAL GENITOURINARY CANCER (2019)
PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations
Yongshuai Jiang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
PD-L1 Expression and Immune Cell In fi ltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative Activity
Martina Ferrata et al.
FRONTIERS IN ONCOLOGY (2019)
Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism
Jingjing Zhu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
Wei Xiao et al.
MOLECULAR CANCER RESEARCH (2019)
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma Findings of the Phase 1b KEYNOTE-028 Study
Roger B. Cohen et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
CART cells are prone to Fas- and WDR5-mediated cell death
Benjamin O. Tschumi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
Judith A. Seidel et al.
FRONTIERS IN ONCOLOGY (2018)
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
Jingjing Zhu et al.
NATURE COMMUNICATIONS (2017)
Combined evaluation of the FAS cell surface death receptor and CD8+tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer
Erik J. Blok et al.
ONCOTARGET (2017)
Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance
Akiko Yamada et al.
Frontiers in Immunology (2017)
Overview of the 8th Edition TNM Classification for Head and Neck Cancer
Shao Hui Huang et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors
Tomoyuki Igarashi et al.
ESMO OPEN (2016)
The role of CD95 and CD95 ligand in cancer
M. E. Peter et al.
CELL DEATH AND DIFFERENTIATION (2015)
Development of an Automated PD-L1 Immunohistochemistry (IHC) Assay for Non-Small Cell Lung Cancer
Therese Phillips et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2015)
Epidemiology, Prognostic Factors, and Treatment of Malignant Submandibular Gland Tumors A Population-Based Cohort Analysis
Robert J. Lee et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2015)
Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)
Susana Cedres et al.
PLOS ONE (2015)
Zonal differences in PD-1 expression in centre of tumour versus periphery in microsatellite stable and unstable colorectal cancer
Grainne O'Kane et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
FAS system deregulation in T-cell lymphoblastic lymphoma
M. Villa-Morales et al.
CELL DEATH & DISEASE (2014)
CD95-mediated cell signaling in cancer: mutations and post-translational modulations
Sebastien Tauzin et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Recurrent Salivary Gland Cancer
M. Boyd Gillespie et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2012)
Salivary gland carcinomas
Tobias Ettl et al.
ORAL AND MAXILLOFACIAL SURGERY-HEIDELBERG (2012)
Theileria parva-transformed T cells show enhanced resistance to Fas/Fas ligand-induced apoptosis
P Küenzi et al.
JOURNAL OF IMMUNOLOGY (2003)
Inverse relation of Fas-ligand and tumor-infiltrating lymphocytes in angiosarcoma -: Indications of apoptotic tumor counterattack
C Zietz et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity
RM Siegel et al.
NATURE IMMUNOLOGY (2000)
Granule exocytosis, and not the Fas/Fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4+ as well as CD8+ cytotoxic T lymphocytes in humans
M Yasukawa et al.
BLOOD (2000)
分享论文
